Cargando…

The anemia-independent impact of myelodysplastic syndromes on health-related quality of life

Myelodysplastic syndromes (MDS) are in the majority of cases characterized by anemia. Both anemia and MDS per se may directly contribute to impairments in health-related quality of life (HRQoL). In this study, we aimed to investigate the anemia-independent impact of MDS on HRQoL. We evaluated partic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wouters, Hanneke J. C. M., Conrads-Frank, Annette, Koinig, Karin A., Smith, Alex, Yu, Ge, de Witte, Theo, Wolffenbuttel, Bruce H. R., Huls, Gerwin, Siebert, Uwe, Stauder, Reinhard, van der Klauw, Melanie M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592948/ https://www.ncbi.nlm.nih.gov/pubmed/34476573 http://dx.doi.org/10.1007/s00277-021-04654-1

Ejemplares similares

Association of anemia with health-related quality of life and survival: a large population-based cohort study
por: Wouters, Hanneke J.C.M., et al.
Publicado: (2019)

The Association Between Anemia and Skin Autofluorescence, a Marker for Advanced Glycation End Product Accumulation
por: Wouters, Hanneke J.C.M., et al.
Publicado: (2020)

Development of a core outcome set for myelodysplastic syndromes – a Delphi study from the EUMDS Registry Group
por: Rochau, Ursula, et al.
Publicado: (2020)

Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists
por: Stojkov, Igor, et al.
Publicado: (2021)

Association Between Peripheral Blood Cell Count Abnormalities and Health-Related Quality of Life in the General Population
por: Wouters, Hanneke J. C. M., et al.
Publicado: (2020)

Hypothyroidism, comorbidity and health-related quality of life: a population-based study
por: Wouters, Hanneke J C M, et al.
Publicado: (2023)

Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project
por: Efficace, Fabio, et al.
Publicado: (2022)

Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study
por: Stojkov, Igor, et al.
Publicado: (2023)

The Many Faces of Cobalamin (Vitamin B(12)) Deficiency
por: Wolffenbuttel, Bruce H.R., et al.
Publicado: (2019)

Patient‐reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis
por: Stauder, Reinhard, et al.
Publicado: (2020)

Epidemiology of thyroid disorders in the Lifelines Cohort Study (the Netherlands)
por: Wouters, Hanneke J. C. M., et al.
Publicado: (2020)

Active smoking and macrocytosis in the general population: Two population‐based cohort studies
por: Eisenga, Michele F., et al.
Publicado: (2018)

Malnutrition in Older Patients With Hematological Malignancies at Initial Diagnosis – Association With Impairments in Health Status, Systemic Inflammation and Adverse Outcome
por: Stauder, Reinhard, et al.
Publicado: (2020)

The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients
por: Stauder, Reinhard
Publicado: (2012)

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
por: Hoeks, Marlijn, et al.
Publicado: (2020)

Clonal evolution in myelodysplastic syndromes
por: da Silva-Coelho, Pedro, et al.
Publicado: (2017)

PB2007: INTEGRATION OF TELEHEALTH IN DAILY CLINICAL PRACTICE IN PATIENTS WITH MYELODYSPLASTIC NEOPLASMS - STATUS QUO AND FUTURE PERSPECTIVES
por: Stauder, Reinhard, et al.
Publicado: (2023)

Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
por: Wolffenbuttel, Bruce H. R., et al.
Publicado: (2017)

A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general population
por: Boersma, Henderikus E., et al.
Publicado: (2022)

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes
por: de Swart, Louise, et al.
Publicado: (2018)

Genome-wide association study identifies novel loci associated with skin autofluorescence in individuals without diabetes
por: Vollenbrock, Charlotte E., et al.
Publicado: (2022)

Megaloblastic Anemia with Ring Sideroblasts is not Always Myelodysplastic Syndrome
por: Narang, Neha Chopra, et al.
Publicado: (2016)

Pernicious anemia: a myelodysplastic syndrome look-alike
por: Kesbeh, Yazeed, et al.
Publicado: (2019)

Differences in lipid and blood pressure measurements between individuals with type 1 diabetes and the general population: a cross-sectional study
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2023)

Lutetium-177 Dotatate-Induced Hemolytic Anemia and Myelodysplastic Syndrome
por: Alkassis, Samer, et al.
Publicado: (2022)

Lower‐risk myelodysplastic syndromes: Current treatment options for anemia
por: Meunier, Mathieu, et al.
Publicado: (2022)

Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy
por: Hofer, F., et al.
Publicado: (2018)

The cancer patient’s perspective of COVID‐19‐induced distress—A cross‐sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic
por: Koinig, Karin A., et al.
Publicado: (2021)

Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort
por: Bach, Veronika, et al.
Publicado: (2014)

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome
por: Májek, Pavel, et al.
Publicado: (2013)

Severe atypical herpes zoster as an initial symptom of fatal myelodysplastic syndrome with refractory anemia and blast excess (RAEB II)
por: Wollina, Uwe, et al.
Publicado: (2017)

Occupational therapy for persons with cognitive impairments
por: Schnell-Inderst, Petra, et al.
Publicado: (2023)

Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes
por: Giudice, Valentina, et al.
Publicado: (2018)

Comment: In Response to “Megaloblastic Anemia with Ring Sideroblasts is not Always Myelodysplastic Syndrome”
por: Gajendra, Smeeta
Publicado: (2017)

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm
por: Füreder, Wolfgang, et al.
Publicado: (2016)

The impact of erythroblast enucleation efficiency on the severity of anemia in patients with myelodysplastic syndrome
por: An, Chao, et al.
Publicado: (2023)

Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer—A Systematic Review
por: Sroczynski, Gaby, et al.
Publicado: (2020)

Impaired Mitophagy of Nucleated Erythroid Cells Leads to Anemia in Patients with Myelodysplastic Syndromes
por: Jiang, Huijuan, et al.
Publicado: (2018)

Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The “Seed and Soil” Crosstalk
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options
por: Lewis, Russell, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j20fogl7uf4pb3lt1vgsdqi13i